Rheumatologic Consequences of Immunotherapy to Treat Certain Cancers | Johns Hopkins Medicine

preview_player
Показать описание
Dr. Cappelli's research interest involves collaboration with oncologists to study patients developing rheumatic diseases after being treated for their cancer by a new oncology drug.
Рекомендации по теме